Evaluating how well patients in Italy stick to and benefit from Inclisiran treatment for high cholesterol
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - CHOLINET (CHOLesterol Italian Inclisiran NETwork)
This study looks at how well people in Italy stick to their Inclisiran treatment for high cholesterol and whether it helps them improve their health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Federico II University Academic / other |
| Locations | 1 site (Naples) |
| Trial ID | NCT06287177 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the adherence, persistence, and efficacy of Inclisiran treatment among patients with hypercholesterolemia in Italy. By monitoring real-life patient experiences, the study seeks to gather valuable data on how well patients follow their treatment regimen and the outcomes they achieve. The study will involve patients currently receiving Inclisiran, providing insights into its effectiveness in a practical setting. The findings could help inform future treatment strategies and guidelines for managing high cholesterol.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 18 to 80 who are currently undergoing treatment with Inclisiran.
Not a fit: Patients under 18 years or over 80 years, as well as those who refuse to participate, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of Inclisiran's effectiveness and improve treatment adherence for patients with high cholesterol.
How similar studies have performed: While this study focuses on real-life adherence and efficacy, similar studies evaluating treatment adherence have shown promising results in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients under Inclisiran treatment Exclusion Criteria: * Age \< 18 years o \> 80 years * Patients who refuse to participate and to sign informed consent
Where this trial is running
Naples
- Federico II University of Naples, Department of Advanced Biomedical Sciences — Naples, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.